Next Article in Journal
KRAS Mutant Pancreatic Cancer: No Lone Path to an Effective Treatment
Previous Article in Journal
Computed Tomography Demonstration of the Production and Distribution of Oxygen Gas Following Intratumoral Injection of a New Radiosensitizer (KORTUC) for Patients with Breast Cancer—Is Intratumoral Injection Not an Ideal Approach to Solve the Major Problem of Tumor Hypoxia in Radiotherapy?
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Cancers
Volume 8
Issue 4
10.3390/cancers8040044
cancers-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Expression of Concern: Cancers 2010, 2(3), 1683-1688.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Expression of Concern

Expression of Concern: Takai, N. and Narahara, H. Epigenetic Therapy in Human Choriocarcinoma. Cancers 2010, 2, 1683–1688

by
Cancers Editorial Office
MDPI AG, Klybeckstrasse 64, CH-4057 Basel, Switzerland
Cancers 2016, 8(4), 44; https://doi.org/10.3390/cancers8040044
Submission received: 6 April 2016 / Accepted: 6 April 2016 / Published: 7 April 2016
Versions Notes
We wish to make readers aware that text in [1] has been taken from other publications by the same author. In particular, much of Section 1, the first part of Section 2 and the first sentence of Section 3 are copied verbatim from [2]. Table 1 and the second part of Section 2 are taken from [3]. The main novel contribution of [1] lies in Section 3. We regret that these issues were not picked up before publication and wish to apologize to readers of Cancers.

References

  1. Takai, N.; Narahara, H. Epigenetic therapy in human choriocarcinoma. Cancers 2010, 2, 1683–1688. [Google Scholar] [CrossRef] [PubMed]
  2. Takai, N.; Narahara, H. Histone deacetylase inhibitor therapy in epithelial ovarian cancer. J. Oncol. 2010, 2010, 458431. [Google Scholar] [CrossRef] [PubMed]
  3. Takai, N.; Narahara, H. Preclinical studies of chemotherapy using histone deacetylase inhibitors in endometrial cancer. Obstet. Gynecol. Int. 2010, 2010, 923824. [Google Scholar] [CrossRef] [PubMed]

Share and Cite

MDPI and ACS Style

Cancers Editorial Office. Expression of Concern: Takai, N. and Narahara, H. Epigenetic Therapy in Human Choriocarcinoma. Cancers 2010, 2, 1683–1688. Cancers 2016, 8, 44. https://doi.org/10.3390/cancers8040044

AMA Style

Cancers Editorial Office. Expression of Concern: Takai, N. and Narahara, H. Epigenetic Therapy in Human Choriocarcinoma. Cancers 2010, 2, 1683–1688. Cancers. 2016; 8(4):44. https://doi.org/10.3390/cancers8040044

Chicago/Turabian Style

Cancers Editorial Office. 2016. "Expression of Concern: Takai, N. and Narahara, H. Epigenetic Therapy in Human Choriocarcinoma. Cancers 2010, 2, 1683–1688" Cancers 8, no. 4: 44. https://doi.org/10.3390/cancers8040044

APA Style

Cancers Editorial Office. (2016). Expression of Concern: Takai, N. and Narahara, H. Epigenetic Therapy in Human Choriocarcinoma. Cancers 2010, 2, 1683–1688. Cancers, 8(4), 44. https://doi.org/10.3390/cancers8040044

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop